Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02391727
Title Safety, Immunogenicity and Pharmacokinetics of SYN004 in Patients With Solid Tumors (SYN004_Ph_1)
Acronym SYN004_Ph_1
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Synermore Biologics Co., Ltd.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.